Cargando…

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis

OBJECTIVE: This study aimed to analyze the healthcare resource use (HCRU) and associated costs of multiple myeloma (MM) using German claims data. METHODS: Anonymized claims data from one of the largest sickness funds in Germany were analyzed. Costs and HCRU were calculated from the perspective of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocaata, Zeki, Wilke, Thomas, Fischer, Franz, Welte, Robert, Einsele, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283612/ https://www.ncbi.nlm.nih.gov/pubmed/35750956 http://dx.doi.org/10.1007/s41669-022-00344-4

Ejemplares similares

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events
por: Hardtstock, Fränce, et al.
Publicado: (2021)

Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis
por: Quignot, Nadia, et al.
Publicado: (2023)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014–2019: a retrospective cohort study
por: Hu, Tianyan, et al.
Publicado: (2023)

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
por: Canbay, Ali, et al.
Publicado: (2021)

Healthcare resource utilization and costs in 23–25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany – a retrospective analysis of statutory health insurance claims data
por: Reuschenbach, Miriam, et al.
Publicado: (2022)

Real‐world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore
por: Bayani, Diana Beatriz, et al.
Publicado: (2023)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
por: Schroeder, Krista M, et al.
Publicado: (2019)

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
por: Borchmann, Peter, et al.
Publicado: (2022)

Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis
por: Schorling, Elisabeth, et al.
Publicado: (2023)

Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis
por: Blaschke, Katja, et al.
Publicado: (2021)

Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany
por: Christensen, Stefan, et al.
Publicado: (2019)

Use of Biologic Therapies in the Treatment of Asthma – A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation
por: Hardtstock, Fraence, et al.
Publicado: (2022)

Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study
por: Tada, Yayoi, et al.
Publicado: (2022)

Preferences of Patients with Chronic Hepatitis B – A Discrete Choice Experiment on the Acceptability of Functional Cure
por: Hardtstock, Fraence, et al.
Publicado: (2020)

Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
por: Gauthier, Geneviève, et al.
Publicado: (2017)

Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
por: Chandler, David, et al.
Publicado: (2021)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study
por: Owens, Anjali T., et al.
Publicado: (2022)

POSA52 A Year-on-Year Comparison Overall German Healthcare Resource Utilization in COVID Versus Non-COVID Times: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use
por: Appukkuttan, Sreevalsa, et al.
Publicado: (2019)

Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
por: Chandler, David, et al.
Publicado: (2023)

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016)

Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis
por: de Lepper, Marion, et al.
Publicado: (2023)

Comparing costs and health care resource utilization between nmHSPC and mHSPC patients: a retrospective claims analysis
por: Ko, Gilbert Chao, et al.
Publicado: (2022)

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis
por: Cheng, Ssu-Wei, et al.
Publicado: (2018)

Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study
por: Kreis, Kristine, et al.
Publicado: (2020)

Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
por: Bokemeyer, Bernd, et al.
Publicado: (2022)

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
por: Schwarting, Andreas, et al.
Publicado: (2021)

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis
por: Olson, Amy L., et al.
Publicado: (2022)

Complications, Costs, and Healthcare Resource Utilization After Staged, Delayed, and Immediate Free-Flap Breast Reconstruction: A Longitudinal, Claims-Based Analysis
por: Shammas, Ronnie L., et al.
Publicado: (2022)

Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
por: Zhou, Xiang, et al.
Publicado: (2020)

Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis
por: Mehta, Rajesh R., et al.
Publicado: (2020)

Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis
por: Toro, Walter, et al.
Publicado: (2023)

Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database
por: Sato, Masayo, et al.
Publicado: (2016)

Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
por: Schultz, Neil M., et al.
Publicado: (2018)

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016
por: Zah, Vladimir, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9100hbs5792qshg6p6u7mdtm2d